Strategic Growth ReWalk is a small to mid-sized medical device company with a focus on gait training and mobility for lower limb disabilities, presenting a sales opportunity to expand adoption beyond current stroke rehabilitation and spinal cord injury solutions, including potential expansion into additional mobility impairment segments.

Board and Leadership Recent board activity with new director appointments and a leadership transition indicates evolving governance and potential strategic pivots; engage to align on long-term commercialization plans and potential partnerships or co-development opportunities.

Technology & IP The company emphasizes robotic exoskeletons and wearable exoskeleton technology with ongoing next-generation development; position offerings around innovation leadership, integration with digital health platforms, and enhanced clinician training support.

Partnership & M&A Notable acquisition of AlterG suggests openness to strategic acquisitions or collaborations to augment capabilities; explore co-development, distribution agreements, or technology licensing to accelerate market reach.

Funding Leverage With significant funding runway but revenue under one million, there is a need for scalable commercial channels and reimbursement-focused strategies; propose joint go-to-market plans, payer engagement, and field sales support to drive revenue growth.